Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gua Xie Xin Tong Di Wan
- Development stage
- Unknown
- Lead developer
- Fuguan Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Gua Xie Xin Tong Di Wan (瓜薤心通滴丸) is a novel Traditional Chinese Medicine (TCM) drug under development for the treatment of coronary heart disease and angina pectoris. It is designed to address conditions characterized by "chest yang deficiency and phlegm-stasis obstructing the collaterals" (胸阳不振、痰瘀阻络) according to TCM principles. Clinical studies have indicated its potential to improve clinical efficacy, regulate blood lipid levels (specifically total cholesterol), and enhance hemorheology in affected patients. The drug has also demonstrated effects such as improving myocardial tolerance to ischemia and hypoxia, inhibiting platelet aggregation, preventing atherosclerosis, and reducing thrombus formation. Developed by a consortium led by Hubei Fuguan Pharmaceutical Co., Ltd., it has completed Phase II clinical trials and is slated to enter Phase III.
- Other names
- Gua Xie Xin Tong瓜薤心通
Beyond the preview
Go deeper on Gua Xie Xin Tong Di Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gua Xie Xin Tong Di Wan.